FAQ & Interpretations

Below is a list of standards linked to Frequently Asked Questions and their responses. Please review the list and if you do not find an answer to your specific question, click on the link below the list to submit your inquiry to “Interpretations.”

    CORE (v2.1)

    CORE 1- Organizational Structure
    CORE 7- Staff Training Program
    CORE 10 & 11- Senior Clinical Staff Requirements and Senior Clinical Staff Responsibilities
    CORE 14- Business Relationships
    CORE 15-18- Oversight of Delegated Functions
    CORE 25- Access to and Monitoring of Services
    CORE 32- Quality Management Committee

    P/N: Credentialing (v5.1)

    P/N-CR 9- Primary Source Verification

    Health UM (v5.1)

    HUM 1-30
    HUM 10- Initial Clinical Reviewer Qualifications
    HUM 15 & 16- Peer-to-Peer Conversation Availability and Peer-to-Peer Conversation Alternate
    HUM 31- Appeals Process
    HUM 32- Appeal Peer Reviewer Qualifications
    HUM 32

    Case Management (CM 3.1)

    CM 4- Case Manager Supervisor Qualifications
    CM 4
    CM 9- Case Review
    CM 12- Case Manager Ethics Training
    CM 16- Case Management Consent

    Disease Management (v2.1)

    DM 2- Evidence-Based Practice
    DM 6- Staffing for Disease Management Programs
    DM 8- Methodology for Outcomes Measurement

    Pharmacy Benefit Management (v1.0)

    PBM

 

Can’t find the information that you’re looking for? If so, then click on the link below to submit an Interpretations inquiry.

Interpretations submittal form

 

 

Standard Module: Core Standards
Module Version: 2.1
Standard Number: Core 1
Standard:
CORE 1 – Organizational Structure
The organization has a clearly defined organizational structure outlining direct and indirect oversight responsibility throughout the organization.
Question: In URAC’s accreditation guide documentation there are multiple references to "the program" beginning in Core 1. What does URAC mean by this? Does "the program" refer to the Utilization Management program (which we call the Medical Review Unit) or does it refer to activities provided by the whole organization?
Response: The “program” referred to throughout URAC’s support material is the function or services covered by the accreditation for which the organization (“applicant”) is applying. For Core 1, the applicant is asked to provide organizational structure, reporting structure, and delivery model including a description of key stakeholders in the organization’s health care-related function or program.  The intent here is to illustrate the organization’s structure and where in that overall structure the function covered by the accreditation is being performed.

For Core-only applicants, the program might be referring to health-care related services such as professional training, software development, consulting, shredding/document management, information systems security, etc.  For applicants applying for one or more of the other URAC accreditations, it would be the function for which the applicant is seeking accreditation (e.g., Health Utilization Management, Health Plan, Claims Processing, etc.)  Note that this does not include general personnel, accounting, office management, and other such support services for the organization.

 

 

Standard Module: Core Standards
Module Version: 2.1
Standard Number: Core 7
Standard:
CORE 7 – Staff Training Program
The organization has a clearly defined organizational structure outlining direct and indirect oversight responsibility throughout the organization.

The organization has an ongoing training program that includes:
(a) Initial orientation and/or training for all staff before assuming assigned roles and responsibilities;
(b) Ongoing training, at a minimum annually, to maintain professional competency;
(c) Training in current URAC Standards as appropriate to job functions;
(d) Training in state and regulatory requirements as related to job functions;
(e) Conflict of interest;
(f) Confidentiality;
(g) Training on identification and prevention of fraud and abuse, as appropriate to job functions;
(h) Delegation oversight, if necessary; and
(i) Documentation of all training provided for staff.

Question: Please advise on the frequency and types of training required to meet Core 7c, d, e, f and g. A review of the standard appears to indicate that training during the initial orientation and or general training of Core 7(c-g) is sufficient to meet the standard.  Core 7(b) clearly requires a minimum of annually regarding professional competency.  Is this interpretation correct?

Response: Orientation and ongoing training programs help to ensure that staff are kept up-to-date and have the knowledge and resources to provide quality program services. Training may vary by profession and the type of organization. The standard is silent on frequency of training.

Examples of training include: Obtaining continuing education credits in a relevant field. Attendance at meetings or conferences related to job functions In-house on performance of job functions. Ongoing training should be documented in personnel files. Regarding Core 7(c) and (d): Staff need only be trained in those URAC standards and regulations that apply directly to their job and not all standards and regulations that affect the organization.

 

 

Standard Module: Core, Health Utilization Management & Case Management Standards
Module Version: 2.1, 5.1 & 3.1
Standard Number: Core 10 & 11
Standard:
CORE 10 – Senior Clinical Staff Requirements

The organization designates at least one senior clinical staff person who has:
(a) Current, unrestricted clinical license(s) (or if the license is restricted, the organization has a process to ensure job functions do not violate the restrictions imposed by the state licensure board);
(b) Qualifications to perform clinical oversight for the services provided; and
(c) Post-graduate experience in direct patient care; and
(d) Board certification (if the senior clinical staff person is an M.D. or D.O.).

CORE - 11 - Senior Clinical Staff Responsibilities

A senior clinical staff person:
(a) Provides guidance for all clinical aspects of program;
(b) Is responsible for clinical aspects of program; and
(c) Has periodic consultation with practitioners in the field.

Question: With regards to Core Standard 10 and 11, in the interpretive guide it indicates URAC generally expects that the organization providing general health services, products or management, that the senior clinical staff is a MD or DO.  We are sitting for accreditation for case management only. We do have a medical director, but he is contracted to provide services as needed.  We provide case management services; we are not an insurance company nor do we approve or deny services (i.e., perform utilization review).  Do we need to have an MD or DO on staff in the Senior Clinical position?

Response: Fore Case Management organizations, it is not required that the senior clinical staff person be a physician; however, the case management standards require that the case managers have access to a physician that has experience to the type of program under consideration. 

The senior clinical staff person for a Utilization Management program must be an MD or DO for general health and welfare review programs.  In addition, board eligible does not meet Core 10(d).  Though the senior clinical staff person may not work full time, work remotely, or may be a contracted individual instead of an employee, it is incumbent upon the organization to provide evidence that this individual is qualified pursuant to Core 10 and fulfills the accountabilities identified in Core 11.

 

 

Standard Module: Core Standards
Module Version: 2.1
Standard Number: Core 14
Standard:
CORE 14 – Business Relationships

The organization maintains signed written agreements with all clients describing the scope of the business arrangement.

Question: Do we need to submit a master list naming all of the clients with whom we do business, or are the sample template agreements enough?

Response: Either one of the documents mentioned would meet the desk top phase requirements of the standard, but most organizations would never submit a full client list since it is proprietary information. If you have a client/payer for whom you wrote the contract (template) for, you could submit one of those as a sample for the application documentation. Another alternative would be to submit the internal contracts department policy and procedure which defines when and how the client/payer contracts are reviewed and renewed.

Standard Core 14 is further evaluated during the onsite survey, where URAC reviewers speak to the network or contract manager to verify the process whereby they review and renew existing contracts for needed changes.  The reviewer would then examine 2-3 of your client payer contracts, which are related to the services under accreditation. These contracts are examined for: a reference to the contracted service under accreditation, a current in-force date, and the authorizing authorities.

 

 

Standard Module: Core Standards
Module Version: 2.1
Standard Number: Core 15-18
Standard:
Oversight of Delegated Functions
Question: We are in the process of obtaining additional state UM licenses for potential future administration of fully insured plans. With reference to Core 15, 16, 17 and 18, where there is a State-mandated external review process, do we need to comply with the delegation standards since this is an external process and we would have no contracts with these state certified vendors?
Response: In response to your Interpretations inquiry below: A state-mandated IRO is not delegation and therefore standards Core 15-18 are not applicable. In cases where an applicant organization has a contract with and therefore is delegating to an IRO, then standards Core 15-18 are applicable; however, if the IRO is URAC accredited, then the applicant organization is exempt from standards Core 15, 16 and 18 (Core 17 would still apply).

Your organization should have a policy and procedure reflecting the UM processes for any state mandating independent review, whether it involves an IRO that you contract with or one that the state contracts with. URAC would also expect your compliance program documentation related to Core 19 to address the applicable state laws. 

 

 

Standard Module: Core Standards
Module Version: 2.1
Standard Number: Core 25
Standard:
CORE 25 – Access to and Monitoring of Services

The organization:
(a) Establishes standards to assure that consumers or clients have access to services: and
(b) Defines and monitors its performance with respect to the access standards.

Question: As a Health Plan when responding to standard Core 25 when discussing access, is it referring to: A) access to provider networks (MDs, etc.) B) access to our staff and services provided by our staff such as educational materials, information on complaint/appeal rights, etc. C) both of the above. Please clarify the term access as it applies to this standard.

Response: The term “access” as it applies to these standards means access to the primary service that an organization provides to health care consumers (i.e., clinical services provided by physicians, etc.) or, in those cases where an organization does not provide services directly to health care consumers, access to the services provided to its clients, as in the case of a health UM organization providing review services for a health plan/MCO.

 

 

Standard Module: Core Standards
Module Version: 2.1
Standard Number: Core 32
Standard:
CORE 32 – Quality Management Committee

The organization has a quality management committee that:
(a) Is granted authority for quality management by the organization's governing body;
(b) Provides on-going reporting to the organization’s governing body;
(c) Meets at least quarterly;
(d) Maintains approved minutes of all committee meetings;
(e) If applicable, includes at least one participating provider or receives input from a participating provider committee (such as a Physician Advisory Group);
(f) Provides guidance to staff on quality management priorities and projects;
(g) Approves the quality improvement projects to undertake;
(h) Monitors progress in meeting quality improvement goals; and
(i) Evaluates the effectiveness of the quality management program at least annually.

Question: Does the standard require that the organization have one QMC or is it acceptable to have 2 committees, one that monitors operational performance and one that monitors clinical performance?

Response: Core 33 requires that a single quality management committee (QMC) has been granted authority for quality management by the organization’s governing body. That QMC may establish permanent or ad hoc sub-committees as needed to address various aspects of quality (i.e., operational, clinical, etc.), but URAC will look for one committee to be accountable to the governing body (e.g., Board of Directors or Senior Management Team, if the organization does not have a Board) for the overall quality management program. This accountability cannot be shared by two separate committees.

 

 


Standard Module: Health Plan/Health Network Credentialing
Module Version: 5.1
Standard Number: P-CR 9 and N-CR 9
Standard:
P/N-CR 9 – Primary Source Verification

The organization verifies the following practitioner credentials using primary sources:
(a) State licensure; and
(b) Board certification, if applicable, or highest level of education.

Question: What are the acceptable sources of primary source verification (PSV) for Board Certification?

Response: Since the American Board of Medical Specialties (ABMS) is a designated primary equivalent source for verification of board certification by its Member Boards, where it releases this verification information to other entities, it must identify those that it considers primary and those that are not.  In turn, URAC recognizes those sources that the ABMS has designated as primary equivalents as ones that are primary as well. 

The ABMS has indicated that two products published by Elsevier Science, "The Official ABMS Directory of Board Certified Medical Specialists" and the CD "ABMS Medical Specialists Plus" as ones that are not to be used for primary source verification (PSV), in part since the complete physician date of birth has been removed from these sources.  I will refer you to the document entitled, “Official ABMS® Display Agent List” dated September 15, 2006, found on the ABMS website:

http://www.abms.org/Who_We_Help/Professional_Organizations/pdf/DisplayAgentList.pdf.  Of note, the ABMS recognizes Elsevier’s “BoardCertifiedDocs” as a service providing primary equivalent source data on behalf of the ABMS.  In addition, the ABMS indicates that it offers a number of alternate PSV source options and is prepared to assist organizations in selecting the one that is best suited for their needs.

 

 


Standard Module: Health Utilization Management
Module Version: 5.1
Standard Number: HUM 1-30
Question: Does URAC consider the determination of whether a treatment or service is or is not "experimental" or "investigational" to be within the scope of "utilization review" and therefore subject to its standards? Our question does not focus on whether a particular service, procedure, drug or device was or was not in benefit; our concern is with the medical evaluation of same.  When a payer makes a medical determination that a service, procedure, drug or device is "experimental" and/or "investigational" and the attending physician disagrees based upon his perspective of prevailing practice, peer reviewed literature, etc., we would classify the appeal of such "non-certification" as falling within the four corners of our state law that addresses medical determinations of the necessity and appropriateness of care, drugs and devices.  We were interested in knowing whether URAC concurred on this point.
Response: Up to the point of requesting an appeal of the non-certification due to an initial determination that the service or treatment is experimental or investigational, the process is covered by URAC’s Health Utilization Management Standards (e.g., HUM 1‑30); the subsequent appeal process is covered by URAC’s Health Plan Standards (e.g., Core 11, Core 27‑29 and P‑UM 1) cited below.

CORE 11 – Senior Clinical Staff Responsibilities

The senior clinical staff person:
(a) Provides guidance for all clinical aspects of program;
(b) Is responsible for clinical aspects of program; and
(c) Has periodic consultation with practitioners in the field.

CORE 27 – Complaint and Appeal System

The organization maintains a system to receive and respond in a timely manner to complaints and, when appropriate, inform consumers of their rights to submit an appeal.

CORE 28 – Appeal Process

The organization maintains a formal appeal resolution process that includes:
(a) Written notice of final determination with an explanation of the reason for the determination;
(b) Notification of the process for seeking further review, if available; and
(c) A reasonable, specified time frame for resolution and response.

CORE 29 – Complaint and Appeal Reporting

The organization reports analysis of the complaints and appeals to the quality management committee.

P-UM 1 – Independent Review Process

The organization has a mechanism for consumers to access an independent review process, after all internal appeal mechanisms have been exhausted, for clinical determinations relating to the necessity or appropriateness of medical services (including determinations that proposed medical services are experimental in nature).  Independent review entities:
(a) Must access and rely on appropriate clinical expertise in rendering independent review determinations;
(b) Must not have any direct financial interest in the organization or in the outcome of the independent review;
(c) Render determinations:
(i) For non-urgent cases, within thirty calendar days from the date the consumer initiated the independent review; and
(ii) For cases involving urgent care, within 72 hours from the date the consumer initiated the independent review;
(d) May not have been involved in the original determination under appeal.

 

 

Standard Module: Health Utilization Management
Module Version: 5.1
Standard Number: HUM 10
Standard:
HUM 10 – Initial Clinical Reviewer Qualifications

Individuals who conduct initial clinical review:
(a) Are appropriate health professionals; and
(b) Possess an active professional relevant license.

Question: Does the URAC Health UM, CM and DM accreditation include staff performing these functions that are telecommuting or working out of a client site?
Response: Yes, staff working offsite – either telecommuting or working at a client site – is included within the scope of the accreditation. URAC reviewers will examine staff files, QM oversight, etc. as it involves this type of staff and URAC reviewers may interview them either telephonically, have them come into the office, or even visit them at their off-site location.

 


Standard Module: Health Utilization Management
Module Version: 5.1
Standard Number: HUM 15 & 16
Standard:
HUM 15 – Peer-to-Peer Conversation Availability

Health professionals that conduct peer clinical review are available to discuss review determinations with attending physicians or other ordering providers.

HUM 16 – Peer-to-Peer Conversation Alternate

When a determination is made to issue a non-certification and no peer-to-peer conversation has occurred:
(a) The organization provides, within one business day of a request by the attending physician or ordering provider, the opportunity to discuss the non-certification decision:
(i) With the clinical peer reviewer making the initial determination; or
(ii) With a different clinical peer, if the original clinical peer reviewer cannot be available within one business day); and
(b) If a peer-to-peer conversation or review of additional information does not result in a certification, the organization informs the provider and consumer of the right to initiate an appeal and the procedure to do so.

Question: Does URAC require the offering of a peer-to-peer conversation for retrospective medical necessity denials?
Response: No, standards HUM 15 and HUM 16 apply to the prospective and concurrent review processes where the request for certification is non-certified by a clinical peer reviewer.

 

 

 

Standard Module: Health Utilization Management
Module Version: 5.1
Standard Number: HUM 31
Standard:
HUM 31 - Appeals Process

As part of the appeals process:
(a) The organization provides the patient, provider, or facility rendering service the opportunity to submit written comments, documents, records, and other information relating to the case, and
(b) Takes all such information into account during the appeals process without regard to whether such information was submitted or considered in the initial consideration of the case, and
(c) In instance of a first level appeal, the organization implements the decision of the first level clinical appeal if it overturns the initial denial.

Definition of Appeal:  Formal request for review of an organizational determination (i.e., services have been denied, reduced, etc.)  Note: Specific terms used to describe appeals vary, and are often determined by law or regulation. URAC’s UM Standards apply to first-level appeal.
Question: Is the UM appeal file review limited to first level appeal, or does it include all levels of appeals?
Response: The scope of URAC’s medical necessity appeal process is limited to the first level of review as indicated by the definition (above) and standard HUM 31(c) (above); therefore, the file review for Health Utilization Management accreditation will be limited to the first level of review.

 


Standard Module: Health Utilization Management
Module Version: 5.1
Standard Number: HUM 32
Standard:
HUM 32 – Appeal Peer Reviewer Qualifications

Appeals considerations are conducted by health professionals who:
(a) Are clinical peers;
(b) Hold an active, unrestricted license to practice medicine or a health profession;
(c) Are board-certified (if applicable) by:
(i) A specialty board approved by the American Board of  Medical Specialties (doctors of medicine); or
(ii) The Advisory Board of Osteopathic Specialists from the major areas of clinical services (doctors of osteopathic medicine);
(d) Are in the same profession and in a similar specialty as typically manages the medical condition, procedure, or treatment as mutually deemed appropriate; and
(e) Are neither the individual who made the original non-certification, nor the subordinate of such an individual.

Question: If new information is received with an appeal request, can a nurse reviewer approve the appeal if the new information meets criteria?
Response: Yes.  Though this process is not specifically addressed in the accreditation guide, it is not prohibited by the standards.  An organization must meet the timeframes required by the standards regardless of any additional steps it may conduct.


 

 

Standard Module: Health Utilization Management
Module Version: 5.1
Standard Number: HUM 32
Standard:
HUM 32 – Appeal Peer Reviewer Qualifications

Appeals considerations are conducted by health professionals who:
(a) Are clinical peers;
(b) Hold an active, unrestricted license to practice medicine or a health profession;
(c) Are board-certified (if applicable) by:
(i) A specialty board approved by the American Board of  Medical Specialties (doctors of medicine); or
(ii) The Advisory Board of Osteopathic Specialists from the major areas of clinical services (doctors of osteopathic medicine);
(d) Are in the same profession and in a similar specialty as typically manages the medical condition, procedure, or treatment as mutually deemed appropriate; and
(e) Are neither the individual who made the original non-certification, nor the subordinate of such an individual.

Question: What is appropriate specialty matching and does the standard of care in a community factor in?  For instance, in our community we have no endocrinologists so our PCPs generally care for their own diabetic patients, but if that patient is in a teaching facility they might be cared for by an Endo.  If there is an appeal by a specialist for a condition, which is generally treated locally by a PCP, who would URAC like to see reviewing the appeal?

Response: When selecting a physician to conduct a medical necessity appeal, first choice would be a specialist in the area of concern for the appeal, even if the physician requesting the appeal is not a specialist.  Physicians with more general practices (e.g., IM, PCP, FP, etc.) may conduct an appeal if they have experience treating the case under review.  When asked to do a review, physicians will tell you if it is not an area they typically treat, in which case you would select another physician to conduct the appeal.  Also, pursuant to the standard, the selected appeal reviewer is “…mutually deemed appropriate” by your organization and the physician requesting the appeal [HUM 32(d)].  So if there is some doubt, it is perfectly acceptable to discuss the selection with the requesting provider.  Also, general practitioners are not used for appeals and it is not appropriate to have a pediatrician review an adult case.

If an endocrinologist or a PCP is managing a diabetic case and has made an appeal, then an endocrinologist would be first choice to conduct the appeal, an IM or PCP with extensive experience in diabetes would be a second choice.  See additional scenarios below.

Scenario 2: Cardiothoracic surgeon performs CABG, patient is newly diagnosed with Diabetes, Endo was consulted and discharge left up to Endo.  Last day was denied and is being appealed.  What kind of specialist should review?  Endo, IM, FP or GP or Cardiothoracic surgeon?

Response: The issue keeping the patient in the hospital was diabetes, so an endocrinologist would review the appeal for the last day of inpatient stay, or IM/FP with extensive experience in diabetes.  General practitioners are typically not used for appeals.

Scenario 3: Pt. was admitted for Chest pain by IM/GP/FP.  Cardiology was consulted. Discharge by attending left up to consultant.  Day denied and appealed.  Who reviews, Cardiology or IM/ FP/GP?

Response: Medical issue could be reviewed by IM/FP or a cardiologist.  General practitioners are typically not used for appeals.

Scenario 4: Pt admitted with new onset of seizures by IM/FP/GP/Peds.  Neuro consult ordered.  Discharge by attending left up to consultant.  Day denied and appealed.  Who reviews, Neuro or IM/FP/GP/Peds?

Response: Neurologist would conduct the appeal since seizures were the reason for the last inpatient day.  If it was a pediatric patient with seizures, then a pediatrician with experience treating those types of patients could conduct the appeal.

Scenario 5: Can FP review for IM for inpatient appeals or does it have to be IM for IM and FP for FP, etc.  

Response: Internal Medicine should review for Internal Medicine, FP for FP.

Scenario 6: Does the matching have to be MD to MD or can it be MD reviewed by DO, etc?

Response: MD and DO can review for each other.

Scenario 7: Can a general surgeon review a case of a Vascular surgeon?

Response: Did the appeal turn on a vascular issue – such as was the vascular surgery necessary?  If yes, then a vascular surgeon would be appropriate to conduct the appeal.  If more of a general surgical issue, then a general surgeon could review the case.

Scenario 8: Do the reviewers just have to have knowledge in the field or truly be "specialty matched"?

Response: Start with the specialty match – you can’t go wrong there.  Then there are general surgeons and internal medicine where they may have extensive experience in a given area, and as such could be used for the appeal.

Scenario 9: IM admits for DVT.  An inpatient day is denied.  Who can review the appeal?  FP or Peds or does it have to be IM?

Response: IM would be best choice; PCP/FP could be used.  Most primary care doctors will tell you if they do not believe they have the background or experience to review a case.  Peds is not a good choice for adult cases.

Scenario 10: FP admits an adult with Pneumonia.  Day is denied.  Can a Pediatrician review?  Must it be FP?  IM?

Response: Pediatrician is not appropriate for an appeal on an adult case.  FP or IM could review the case.

Scenario 11: A 10-wk pregnant patient admitted with DVT by OB.  Vascular surgeon consults and follows, too.  Who can review case for denied days?  Can FP or Pediatrician review concurrently without consulting with a Like Specialist for advice?

Response: It depends upon the reason for the denial and why patient was kept – was there some other reason for the hospital stay?  If it was determined that the DVT condition no longer warranted inpatient stay, then a vascular surgeon, IM or FP could review.  If there was some other complication related to the pregnancy, then an OB would appear to be appropriate.

Scenario 12: Total abdominal hysterectomy performed by GYN surgeon.  Can general surgeon do the appeal review?

Response: If the general surgeon has experience with abdominal hysterectomies, then yes.

Scenario 13: Pulmonologist admits for pulmonary emboli.  Who must review appeal?  IM, FP, Peds or pulmonologist?

Response: Pulmonologist, IM or FP.  Peds should review for pediatric patients.

Scenario 14: Pancreatitis admitted by FP.  Consulted with a general surgeon, but treated medically.  Who should review appeal?

Response: IM or FP.

Scenario 15: GI hemorrhage admitted by GE.  No surgery was required, just scoping and watching. Who should review appeal?  GE, surgeon, IM, FP, Peds?

Response: GE, surgeon or IM.  FP if experience with these types of cases.  Peds should not review adult cases.

Scenario 16: Can a Pediatrician review cases on adults that were admitted by IM or FP or specialists?  Can FP do reviews on neonates being cared for by neonatologists?

Response: No to both scenarios. 

 


Standard Module: Case Management Standards
Module Version: 3.1
Standard Number: CM 4
Standard:
CM 4 – Case Manager Supervisor Qualifications

Individuals who directly supervise case management practices:
(a) Have at least one of the following qualifications: (Primary)
(i) A bachelors (or higher) degree in a health-related field and licensure as a health professional
(where such licensure is available); or
(ii) Certification as a case manager; or
(iii) Professional certification in a clinical specialty and at least three (3) years experience as a
case manager; and
(b) If they have directly supervised the case management process for three or more years, hold a
certification as a case manager.

Question: CM 4 Interpretive Information/Commentary states: "A list of acceptable 'certifications as
a case manager' will be posted on URAC's Web site at www.urac.org." I have searched the
URAC Web site
and cannot locate this list. I would like to be able to include it in our updated manual for Case
Management Staff.
Response: The link has been updated on the Web site to: http://webapps.urac.org/CMcertifications.asp

 


Standard Module: Case Management Standards
Module Version: 3.1
Standard Number: CM 4
Standard:
CM 4 – Case Manager Supervisor Qualifications

Individuals who directly supervise case management practices:
(a) Have at least one of the following qualifications: (Primary)
(i) A bachelors (or higher) degree in a health-related field and licensure as a health professional (where such licensure is available); or
(ii) Certification as a case manager; or
(iii) Professional certification in a clinical specialty and at least three (3) years experience as a case manager; and
(b) If they have directly supervised the case management process for three or more years, hold a certification as a case manager.

Question: CM 4 certification requirement requires individuals who directly supervise case management practices, who have directly supervised the case management process for three or more years to obtain certification as a case manager. The questions are as follows:
1. If a supervisor has directly supervised the case management process for three or more years in another program that is not currently URAC accredited and that supervisor is subsequently assigned to the case management program that will come under URAC view in 2008, does the three years prior supervision count and therefore, certification as a case manager would be required, or does the assignment to the URAC case management program scheduled for review in 2008 count as the first year supervising the case management process?
2. Is “care manager certification” equivalent to case manager certification? Care manager certification is more often associated with licensed social workers and psychologists than with the certified case manager program.
Response:

  1. Pursuant to the Guide, “Points to Remember” second bullet: In CM 4 (b), the CM certification requirement applies to individuals who have held the position of a case management supervisor in the applicant organization for 3 or more years. If the individual has held the position of case management supervisor for less than 3 years at the time of application review, this standard is non-applicable.  
  2. Care manager certification is not equivalent; the standard is specific to case management certification.   

 

 

Standard Module: Case Management Standards
Module Version: 3.1
Standard Number: CM 9
Standard:
CM 9 – Case Review
The organization conducts reviews of the case management process through case review by the case management program director, advisor, or other supervisor to:
(a) Promote achievement of case management goals as established in consumer specific case management plans; and
(b) Report the findings to the quality management committee (See Core Standards, Quality Improvement/Management Section).

Question: Our organization recently went through a downsizing leaving us with one Nurse Case Manager who is our Case Management Supervisor. As a result, the Director of Quality Assurance assumed responsibility for auditing the Nurse Case Manager claims.  Is this arrangement sufficient for purposes of meeting the intent of CM 9?  If not, do you have recommendations for meeting the intent of this standard?
Response: It is acceptable for the Director of Quality to perform quality audits for case management.

 


Standard Module: Case Management Standards
Module Version: 3.1
Standard Number: CM 12
Standard:
CM 12 – Case Manager Ethics Training

The organization establishes, implements, and educates case management personnel, no less than annually, on policies and procedures supporting the ethical framework for case management practice including:
(a) Advocacy for consumer needs;
(b) Guidance for professional relationships with consumers;
(c) Prohibition of relationships that could compromise professional objectivity;
(d) Resolution of conflicts of interest between the case manager, consumer, third party payer, provider or other entity;
(e) Business, financial, and marketing practices;
(f) Resolution of perceived lapses in quality of care resulting from actions by consumers, payers, case managers, providers, organizations or other entities affecting the case management process;
(g) Policies that address case managers’ handling of consumer needs when such needs extend beyond the scope of the organization’s services;
(h) Prohibition of discrimination against a consumer or group of consumers by the case manager or organization; and
(i) Information on how policies regarding the ethical framework will be shared with staff, contractors, clients, and consumers.

Question: I am inquiring if URAC has a point of view or process guideline related to telephonic case managers who also perform formal state utilization review as part of their work in workers compensation cases. I know, for example, from a regulatory perspective case managers cannot do UR on their cases in Massachusetts, but was wondering what the professional/accreditation perspective was if there is not otherwise prohibited by the state.
Response: Pursuant to the URAC Guide “Interpretive Information/Commentary” for standard CM 12, if the Case Manager is involved in benefits determinations, safeguards should be put in place to assure that the role of advocacy is not compromised. Examples include conducting interviews and case file review.  Most organizations conduct an annual review of the organization’s ethical framework for case management practice (along with review of confidentiality policies).  This annual review, which must address all sub-elements in the standard, is documented in each case manager’s file or an attendance sheet is kept to document the review.

 

 

Standard Module: Case Management Standards
Module Version: 3.1
Standard Number: CM 16
Standard:
CM 16 – Case Management Consent

The organization establishes and implements a policy regarding consumers’ consent for participation in case management activities that:
(a) Requires documentation of oral consent;
(b) Requires at minimum an attempt to obtain written consent;
(c) Indicates the time frame in which the consent(s) must be obtained; and
(d) Indicates the duration of validity of the consent(s).

Question: We currently obtain oral consent from individuals we are case managing. This oral consent is documented in our system.  In order to comply with standard CM 16, do we also need to make an attempt to obtain written consent? If so, does URAC have an example of a consent form?
Response: Yes, you must also make an attempt to obtain written consent pursuant to CM 16(b).  Most organizations are meeting this standard by sending out a consent form for case management with an introductory packet. The organization must establish written guidelines for obtaining consent and may allow that consent is not obtained in every case.  If the organization allows exceptions from consent requirements, it should be prepared to justify those exceptions for quality of care, legal, or other valid reasons on a case-specific basis.  It is expected that this consent is obtained from the consumer (patient), but may be from a family member in extenuating circumstances, (e.g., patient is unconscious, a minor, or determined not legally competent).

 

 

 

Standard Module: Case Management Standards
Module Version: 2.1
Standard Number: DM 2
Standard:
DM 2 – Evidence-Based Practice

Disease management practices for each clinical condition are based on scientific evidence and includes input from clinical content expert(s) one of which must include a provider in the specialty area, that:
(a) Is reviewed annually and updated as needed;
(b) Review applicability of clinical practice guidelines to the specific program design;
(c) References publicly available clinical practice guidelines and evidence-based reports that can be accessed by or provided to participating providers; and
(d) Is the basis for establishing the disease management program's objectives for evaluation, clinical quality improvement, consumer education, and outcomes measurement and reporting.
(e) If the program guidelines are modified, a content expert with expertise in the relevant clinical condition(s) must review the guidelines.

Question: Our URAC Workgroup would like a clarification of Disease Management Standard 2 Evidence-Based Practice. In the Scope of Standards section for DM 2 it states "…the applicant must be able to document compliance with this standard for every disease state for which it markets a ‘disease management program.’  The applicant may exclude disease states from the application if compliance cannot be demonstrated.”  Does this mean that only disease states listed on the application may be included in marketing materials?

Response: Standard DM 2 applies to all disease states included within the scope of the accreditation, which may or may not include all of those that your organization offers to the public.  An applicant may choose not to include every disease state program that it currently offers to the public (i.e., includes in its marketing materials).  Note that organizations cannot use the DM accreditation seal to market a disease state that is not within the scope of their accreditation.

 

 

Standard Module: Disease Management Standards
Module Version: 2.1
Standard Number: DM 6
Standard:
DM 6 – Staffing for Disease Management Programs

The disease management program defines the allowable scope of activities for licensed or certified clinical staff and non-licensed or non-certified non-clinical staff in carrying out its disease management activities that:
(a) Is consistent with standards of practice for licensed personnel;
(b) If applicable, allows non-clinical staff to conduct intake, non-clinical data collection, and scripted clinical data collection using appropriate documented instructions and scripts;
(c) Prohibits non-clinical staff from conducting evaluation or interpretation of individual clinical data; and
(d) Provides for supervision of non-clinical staff in the disease management program by licensed or certified staff.

Question: Can a Disease Management program use certified health educators instead of registered nurses (RNs) in their counseling models?
Also, can non-clinical staff collect clinical information and complete general assessments?
Response: Scope of practice for any staff member must be consistent with state professional licensure regulations, certification standards of practice, and federal law. Telephonic programs that interact with callers from various states should determine whether or not additional state licensures are required for the clinical staff. Companies must define the scope of services for clinical and non-clinical staff, as well as the oversight process for staff. Companies that use staff with specialized training should develop criteria for use of these staff members. Specialized training may include board certification, or other certifications of training in health services delivery or health education, for example, nutritionists, certified diabetes educators, physical therapists, or child health specialists. Scope of practice for any staff member must be consistent with state professional licensure regulations, certification standards of practice, and federal law.
Per standard DM 6(b), non-clinical staff may only collect clinical data via “…scripted clinical data collection using appropriate documented instructions and scripts.”  Non-clinical staff may not conduct assessments pursuant to standard DM 6(c), where non-clinical staff is prohibited from conducting evaluation or interpretation of individual clinical data.  Non-clinical staff may not conduct general, free-form assessments and deviations from the script are not allowed.


 

 

Standard Module: Disease Management Standards
Module Version: 2.1
Standard Number: DM 8
Standard:
DM 8 – Methodology for Outcomes Measurement

The disease management program develops or adopts an outcomes measurement methodology for measuring condition specific and overall program performance using valid techniques that address:
(a) Sources of data that will be used to calculate the measurements;
(b) The baseline measurement period and time frame for analysis;
(c) The formula by which the measurement is calculated;
(d) Adjustments that will be made in calculating measures and reporting data; and
(e) Frequency of reporting, which must be at least annual.

Question: What are the specifications for URAC's DM performance reporting on outcomes measures?
Response: URAC is not prescriptive as to the specific fields or format for performance reporting; however, the Disease Management Association of America (DMAA) has various publications for measuring outcomes www.dmaa.org.  For each condition, documentation of specific measurement objectives consistent with identified evidence-based guidelines is one of the expected types of information to be included in the reporting.  URAC will verify that the disease management program documents its general methodology for each type of performance measure and documentation for standard DM 8 should address the methodology for measuring performance in clinical, financial, consumer reported and provider performance domains.


 

PBM

1.   What do pharmacy benefit management (PBM) organizations do?

Pharmacy benefit management organizations work like a health plan for drugs.  They manage drug benefits on behalf of employers, negotiating preferred pricing for drugs, determining pharmacy networks, and developing and maintaining a “formulary”—the list of covered or preferred medications--with the goal of helping purchasers reduce costs.  They can either work in partnership with a health plan to provide services, or can work as a stand-alone service.  Employers use these services to lower costs because the cost of pharmaceuticals represents more than 12 percent of total health spending, a significant proportion of their total health expenditure.

2.   Why is URAC’s Pharmacy Benefit Management (PBM) Accreditation a good idea?

The lion’s share of insured Americans receive PBM services, yet URAC’s accreditation program is the first to give comprehensive, third-party assurance for consumers and purchasers that quality standards were met for consumer protection and empowerment, appropriate access to drugs and pharmacies, patient safety, and disclosure of pricing and contracting terms

  • In 2005 alone, Americans spent more than $170 billionfor prescriptions at retail pharmacies.  This staggering dollar figure represents more than 3.1 billion individual retail prescriptions filled or re-filled—and doesn’t include some 244 million prescriptions filled via mail order pharmacy.  
  • Some 70 percent of those prescription drug transactions were managed by a prescription benefit management (PBM) program. 
  • Pharmacy related expenses in the United States were expected to reach $250 billion in 2006, representing an 11.5 percent increase over 2005.  
  • The sector saw rapid expansion with the introduction of Medicare Part D prescription drug coverage in 2006, with more than 39 million Medicare beneficiaries (90 percent) now enrolled in that program.

The need for additional consumer protection and safety guidelines is an area of concern for many. The final rule implementing the Medicare Modernization Act of 2003 (MMA) included specific language addressing some of the key issues surrounding PBM practices, and included an invitation from the Centers for Medicare and Medicaid Services (CMS) for industry self-regulation. The regulation recognizes third party accreditation programs to create recognition for:

  • Access to covered Part D drugs including the pharmacy access requirements and the use of standardized technology and formulary requirements;
  • Drug utilization management, Quality Assurance, Medication Therapy Management, and a program to control fraud, waste and abuse; and
  • Confidentiality and accuracy of enrollee records.

URAC’s new Pharmacy Benefit Management Accreditation addresses many of these concerns.

3.   How do URAC’s Pharmacy Benefit Management (PBM) Accreditation standards benefit consumers?
The standards require organizations have policies and procedures in place that ensure:

  • Access to appropriate drugs
  • Protection of health information
  • Customer service center operations and performance standards, such as timeliness and performance in answering telephone inquiries, or reasonable and accessible hours or operation.
  • Complaint and appeals tracking and resolution
  • Drug safety issues identification, resolution, and informing consumers promptly.  For instance, the standards examine policies and procedures that govern pharmacy networks and how they ensure drug safety protocols at the pharmacy level—issues such as drug interactions, whether a drug is appropriate for the consumer’s age and gender, or whether there are drug alerts that apply.
  • Accessibility and reliability of information intended for consumers, such as availability of provider directories or information about formularies and benefit coverage.
  • Methods to measure customer satisfaction
  • Access, availability, and quality and safety criteria in the pharmacy network (including any way drugs are distributed, such as retail and specialty clinics).

4.   How do URAC’s Pharmacy Benefit Management (PBM) Accreditation standards help purchasers? 
Since purchasers seek PBM services on behalf of consumers, many of the same benefits apply.  In addition to those listed above, the standards require organizations have policies and procedures in place that ensure:

  • Data integrity security, so purchasers know health and personal information about the employees is safe.
  • Disclosure and verification of contractual policies, such as how payment policies with drug manufacturers were developed;
  • Disclosure of what audit rights clients have to ensure pricing methodologies remain transparent.
  • Integrity of the formulary development process.  These include standards surrounding the way drugs are selected for inclusion in formularies, such as the qualifications of those making decisions and that considerations about safety and effectiveness come before cost. 
  • Operational requirements and performance standards, such as licensure and certification of staff.

5.   How do URAC’s Pharmacy Benefit Management (PBM) accreditation standards address clarity in contracting agreements?
The standards require organizations have policies and procedures in place for the purchaser that ensure:

  • Disclosure of rebate structure
  • Disclosure and definition of pricing structure
  • Audit arrangements
  • Formulary decision making

6.   How do URAC’s accreditation standards assure clinical rigor in Pharmacy Benefit Management (PBM) programs?
The standards require organizations have policies and procedures in place that ensure:

  • Clinical decisions and information are developed and delivered with the involvement and oversight of appropriate clinicians to promote optimal and cost effective drug use. 
  • Clinical decisions and information are developed through an evidence-based process.
  • Clinical information undergoes timely review and updates.
  • The Pharmacy and Therapeutics Committee and formulary development and management process is based on efficacy, safety, and therapeutic need.

7.   In what ways do Pharmacy Benefit Management (PBM) organizations benefit from URAC accreditation?
The standards support creation and maintenance of a quality management framework, or a template for policies and procedures that address:

  • Ongoing management of quality procedures, including a quality committee, following a logical blueprint for quality management, maintenance and reporting. 
  • Development and maintenance of written policies and procedures
  • Staff qualifications, credentialing, and oversight requirements of qualified staff for certain functions
  • Development, delivery and expectations of drug utilization management programs
  • Scope of appeals considerations, or procedures in place for how an appeals process works.
  • URAC educational support and training to assist with adherence to standards

8.   In what ways will Pharmacy Benefit Management (PBM) accreditation address areas of interest for regulators?
The standards require organizations have policies and procedures in place such as:

  • Conflict of interest requirements—for staff, committees, or others connected to the organization.  For example, members of a pharmacy and therapeutics or formulary committee cannot have relationships with a drug manufacturer with a product under consideration.   
  • Safeguards to ensure that financial incentives do not create conflicts of interest.
  • Access to drugs and services needed by consumers.
  • Regulatory compliance such as licensure of staff and facilities.

9.   Who can apply for URAC’s Pharmacy Benefit Management (PBM) accreditation program?
Health plans offering these services, or standalone pharmacy benefit management organizations may apply.

10.  How can organizations apply for Pharmacy Benefit Management (PBM) accreditation?
Call URAC at (202) 216-9010.  For more information about the accreditation process, go to http://www.urac.org/healthcare/accreditation.

"Total Number of Retail Prescription Drugs Filled at Pharmacies, 2005." State Health Facts. 2006. Kaiser Family Foundation. 29 Sep 2006 <http://statehealthfacts.org/cgibin/healthfacts.cgi?action=compare&category=Health+Costs+%26+
Budgets&subcategory=Prescription+Drugs&topic=Total+Retail+Rx+Drugs
>.

Pharmacy Benefit Management Market Overview 2006.  April 2006.

Can’t find the information that you’re looking for? If so, then click on the link below to submit an Interpretations inquiry.

Interpretations submittal form

Created by Matrix Group International, Inc